Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. News
  7. Summary
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
End-of-day quote. End-of-day quote Shanghai Stock Exchange - 09/17
152.4 CNY   +5.72%
08/25WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
08/25WUXI APPTEC : Investor Day - WuXi Biology
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

China's Stemirna raises about $200 million to fund COVID-19 vaccine development

06/02/2021 | 10:16pm EDT

BEIJING (Reuters) - China's Stemirna Therapeutics said on Thursday it has raised nearly $200 million to finance clinical trials and production of its COVID-19 vaccine candidate.

Stemirna's candidate, which uses messenger RNA (mRNA) technology is due to enter a Phase II clinical trial soon and has been designed to be effective against variants spreading in South Africa, Brazil and India, Chief Executive Li Hangwen said in the statement.

A Stemirna spokesman said the firm is building two plants which would make the vaccine candidate, each with an annual capacity of 100 million doses, and construction could be completed by August.

The latest fund raising was led by investors including China Merchants Group's health sector investment arm, private equity fund Sequoia Capital China and pharmaceutical firm WuXi AppTec, Stemirna said.

(Reporting by Roxanne Liu and Ryan Woo; Editing by Edwina Gibbs)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
DOW JONES AFRICA TITANS 50 INDEX -0.39% 511.82 Delayed Quote.-3.30%
DOW JONES SOUTH AFRICA(ZAR) 0.94% 1823.99 Delayed Quote.2.46%
EURO / BRAZILIAN REAL (EUR/BRL) -0.03% 6.1994 Delayed Quote.-2.26%
MODERNA, INC. -2.41% 430.05 Delayed Quote.311.65%
S&P AFRICA 40 INDEX 0.38% 167.93 Delayed Quote.-3.30%
WUXI APPTEC CO., LTD. 5.72% 152.4 End-of-day quote.35.75%
All news about WUXI APPTEC CO., LTD.
08/25WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
08/25WUXI APPTEC : Investor Day - WuXi Biology
PU
08/25WUXI APPTEC : Investor Day - WuXi Chemistry
PU
08/25WUXI APPTEC : Investor Day - WuXi Testing
PU
08/13WUXI APPTEC : H1 Profit Surges 56% on Strong Revenue
MT
08/12WuXi AppTec Co., Ltd. Announces Earnings Results for the Half Year Ended June..
CI
08/12WUXI APPTEC : Reports Strong 2021 Interim Results
PU
08/03WUXI APPTEC : STA Completes Acquisition of Bristol Myers Squibb Manufacturing Fa..
PU
07/26WUXI APPTEC : Inside information - proposed disposal of a shares by a shareholde..
PU
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
More recommendations
Financials
Sales 2021 22 383 M 3 462 M 3 462 M
Net income 2021 4 418 M 683 M 683 M
Net cash 2021 11 569 M 1 789 M 1 789 M
P/E ratio 2021 99,2x
Yield 2021 0,26%
Capitalization 448 B 69 350 M 69 354 M
EV / Sales 2021 19,5x
EV / Sales 2022 14,5x
Nbr of Employees 28 542
Free-Float 56,7%
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | 603259 | CNE1000031K4 | MarketScreener
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 152,40 CNY
Average target price 185,83 CNY
Spread / Average Target 21,9%
EPS Revisions
Managers and Directors
Min Zhang Chen Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Ge Li Chairman & President
Ellis Chu Chief Financial Officer & Senior Vice President
Harry He Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
WUXI APPTEC CO., LTD.35.75%69 350
BIONTECH SE340.60%90 003
GILEAD SCIENCES, INC.22.91%89 434
REGENERON PHARMACEUTICALS34.93%67 910
VERTEX PHARMACEUTICALS-20.33%48 539
BEIGENE, LTD.56.02%35 842